Intracellular Fas Ligand Expression Causes Fas-Mediated Apoptosis in Human Prostate Cancer Cells Resistant to Monoclonal Antibody-Induced Apoptosis
Open Access
- 31 October 2000
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 2 (4), 348-358
- https://doi.org/10.1006/mthe.2000.0139
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues.Molecular Pathology, 1997
- Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis)Cytometry, 1997
- An Enhanced Green Fluorescent Protein Allows Sensitive Detection of Gene Transfer in Mammalian CellsBiochemical and Biophysical Research Communications, 1996
- FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling ComplexCell, 1996
- Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell DeathCell, 1996
- Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.The Journal of cell biology, 1996
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- A role for CD95 ligand in preventing graft rejectionNature, 1995
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992